CEPTON INC (CPTN)

US15673X2009 - Common Stock

2.99  +0.01 (+0.34%)

Fundamental Rating

4

Taking everything into account, CPTN scores 4 out of 10 in our fundamental rating. CPTN was compared to 127 industry peers in the Electronic Equipment, Instruments & Components industry. While CPTN has a great health rating, there are worries on its profitability. CPTN is valued quite expensive, but it does show an excellent growth.



0

1. Profitability

1.1 Basic Checks

CPTN had negative earnings in the past year.
In the past year CPTN has reported a negative cash flow from operations.
CPTN had negative earnings in 4 of the past 5 years.
In the past 5 years CPTN always reported negative operating cash flow.

1.2 Ratios

CPTN has a worse Return On Assets (-63.49%) than 88.89% of its industry peers.
Looking at the Return On Equity, with a value of -80.20%, CPTN is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
ROA -63.49%
ROE -80.2%
ROIC N/A
ROA(3y)-86.79%
ROA(5y)-60.13%
ROE(3y)61.12%
ROE(5y)27.65%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of CPTN (27.15%) is comparable to the rest of the industry.
CPTN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

CPTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CPTN has more shares outstanding
CPTN has less shares outstanding than it did 5 years ago.
CPTN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CPTN has an Altman-Z score of -1.78. This is a bad value and indicates that CPTN is not financially healthy and even has some risk of bankruptcy.
CPTN's Altman-Z score of -1.78 is on the low side compared to the rest of the industry. CPTN is outperformed by 77.78% of its industry peers.
There is no outstanding debt for CPTN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.78
ROIC/WACCN/A
WACC7.58%

2.3 Liquidity

CPTN has a Current Ratio of 9.00. This indicates that CPTN is financially healthy and has no problem in meeting its short term obligations.
CPTN's Current ratio of 9.00 is amongst the best of the industry. CPTN outperforms 90.48% of its industry peers.
A Quick Ratio of 8.67 indicates that CPTN has no problem at all paying its short term obligations.
CPTN has a better Quick ratio (8.67) than 91.27% of its industry peers.
Industry RankSector Rank
Current Ratio 9
Quick Ratio 8.67

7

3. Growth

3.1 Past

CPTN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.26%.
Looking at the last year, CPTN shows a very strong growth in Revenue. The Revenue has grown by 75.79%.
Measured over the past years, CPTN shows a very strong growth in Revenue. The Revenue has been growing by 86.58% on average per year.
EPS 1Y (TTM)2.26%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q48%
Revenue 1Y (TTM)75.79%
Revenue growth 3Y86.58%
Revenue growth 5YN/A
Revenue growth Q2Q213.35%

3.2 Future

CPTN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.76% yearly.
Based on estimates for the next years, CPTN will show a very strong growth in Revenue. The Revenue will grow by 137.62% on average per year.
EPS Next Y18.65%
EPS Next 2Y30.91%
EPS Next 3Y24.13%
EPS Next 5Y27.76%
Revenue Next Year122.54%
Revenue Next 2Y150%
Revenue Next 3Y173.06%
Revenue Next 5Y137.62%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CPTN. In the last year negative earnings were reported.
Also next year CPTN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CPTN's earnings are expected to grow with 24.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.91%
EPS Next 3Y24.13%

0

5. Dividend

5.1 Amount

No dividends for CPTN!.
Industry RankSector Rank
Dividend Yield N/A

CEPTON INC

NASDAQ:CPTN (5/1/2024, 7:00:01 PM)

2.99

+0.01 (+0.34%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap47.60M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.49%
ROE -80.2%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 27.15%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 9
Quick Ratio 8.67
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)2.26%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y18.65%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)75.79%
Revenue growth 3Y86.58%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y